Level playing field for
agro-biotech companies
According to media reports, government is planning to set up a
new research facility which will enable smaller firms to
outsource field trials. This will create a level playing field
among biotech companies developing genetically modified (GM)
seeds. Currently smaller biotech firms are at a disadvantage
when it comes undertaking field trials due to high costs, the
high probability of failure, and chance of rejection of field
trials.
Read more...